Westend Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History
Westend Capital Management, LLC
- $285 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
234Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$249 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$207 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$157 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$133 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$130 Million8.76% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.38B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...